PRINCETON DRUG DISCOVERY INC has a total of 14 patent applications. It decreased the IP activity by 90.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are SHANGHAI BEGREAT PHARMATECH, CRYSTAL PHARMATECH CO LTD and GLACEUM INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Organic chemistry methods | |
#5 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | He Kan | 14 |
#2 | Cai Lining | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020123277A1 | Protein kinase inhibitor prodrugs | |
CN108473487A | A kind of kinases inhibitor | |
US2017240545A1 | Inhibitors of protein kinases |